» Articles » PMID: 10445022

Mitotic Checkpoint Inactivation Fosters Transformation in Cells Lacking the Breast Cancer Susceptibility Gene, Brca2

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 1999 Aug 13
PMID 10445022
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The murine Brca2 gene encodes a nuclear protein implicated in DNA repair. Brca2 behaves as a tumor suppressor, but paradoxically, its truncation causes proliferative arrest and spontaneous chromosomal damage. Here, we report that inactivation of cell cycle checkpoints responsive to mitotic spindle disruption, by mutant forms of p53 or Bub1, relieves growth arrest and initiates neoplastic transformation in primary cells homozygous for truncated Brca2. Tumors from Brca2-deficient animals exhibit dysfunction of the spindle assembly checkpoint, accompanied by mutations in p53, Bub1, and Mad3L. The chromosomal aberrations precipitated by Brca2 truncation can be suppressed by mutant forms of Bub1 and p53. Thus, inactivating mutations in mitotic checkpoint genes likely cooperate with BRCA2 deficiency in the pathogenesis of inherited breast cancer, with important implications for treatment.

Citing Articles

BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy.

Sriramulu S, Thoidingjam S, Siddiqui F, Brown S, Movsas B, Walker E Biomolecules. 2024; 14(6).

PMID: 38927028 PMC: 11202206. DOI: 10.3390/biom14060625.


PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation.

Wang J, Chen Y, Li S, Liu W, Zhou X, Luo Y J Clin Invest. 2023; 134(1).

PMID: 37934606 PMC: 10760972. DOI: 10.1172/JCI172137.


Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.

Chen X, Yang C, Wang W, He X, Sun H, Lyu W Front Genet. 2023; 14:1025163.

PMID: 36911389 PMC: 9998954. DOI: 10.3389/fgene.2023.1025163.


Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect.

Yan X, Liu S, Liu C Onco Targets Ther. 2022; 15:1355-1368.

PMID: 36388157 PMC: 9662021. DOI: 10.2147/OTT.S380016.


Single-cell genomic variation induced by mutational processes in cancer.

Funnell T, OFlanagan C, Williams M, McPherson A, McKinney S, Kabeer F Nature. 2022; 612(7938):106-115.

PMID: 36289342 PMC: 9712114. DOI: 10.1038/s41586-022-05249-0.